San Jose, CA, United States of America

John Stuelpnagel

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2014-2022

where 'Filed Patents' based on already Granted Patents

15 patents (USPTO):

Title: Innovations and Contributions of John Stuelpnagel

Introduction

John Stuelpnagel is a prominent inventor based in San Jose, California, known for his significant contributions to the field of genomic analysis. With a total of 15 patents to his name, Stuelpnagel has made remarkable advancements in the understanding of fetal genomic sequences and chromosomal abnormalities.

Latest Patents

One of his latest patents is titled "Processes for calculating phased fetal genomic sequences." This invention provides processes for calculating phased genomic sequences of the fetal genome using fetal DNA obtained from a maternal sample. The innovative processes and systems utilize novel technological and computational approaches to detect fetal genomic sequences and determine the phased heritable genomic sequences. This invention has the potential to identify in utero deleterious mutations carried by the parents and inherited by a fetus within a particular heritable genomic region. Another significant patent is "Assay systems for genetic analysis," which offers assay systems and methods for detecting chromosomal abnormalities and the status of single loci associated with monogenic or polygenic traits in a sample containing nucleic acids from both maternal and fetal sources.

Career Highlights

Throughout his career, Stuelpnagel has worked with notable companies such as Ariosa Diagnostics, Inc. and Roche Molecular Systems, Inc. His work has been instrumental in advancing genetic testing and analysis, contributing to better healthcare outcomes.

Collaborations

Stuelpnagel has collaborated with esteemed colleagues, including Arnold Oliphant and Ken Song, further enhancing the impact of his work in the field of genomics.

Conclusion

John Stuelpnagel's innovative patents and contributions to genomic analysis have significantly advanced the understanding of fetal genetics and chromosomal abnormalities. His work continues to influence the field and improve genetic testing methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…